Womble Bond Dickinson has advised Camden Partners Nexus, a Baltimore-based venture capital firm with a focus on biomedical technology companies, on its participation in an $80m series B investment round in COMPASS Pathways.
COMPASS Pathways, a London-based mental health organization, will use the funding to expand on its lead program in psilocybin therapy for treatment-resistant depression. It will also support further research and advance the company's preclinical pipeline, develop digital technologies and help establish new academic and clinical research partnerships.
Leon Miller, partner, commented:
"It was a pleasure working with our US colleagues to advise Camden Partners Nexus on this Series B investment. Our strong credentials in venture capital coupled with our unique transatlantic offering enabled us to provide the best possible outcome for our client."